Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-30T19:14:02.176Z Has data issue: false hasContentIssue false

Should Parental Refusals of Newborn Screening Be Respected?

Published online by Cambridge University Press:  14 February 2006

AINSLEY NEWSON
Affiliation:
Medical Ethics Unit, Imperial College, London

Extract

For over four decades, knowledge that symptoms of some inherited diseases can be prevented or reduced via early detection and treatment in newborns has underpinned state-funded screening programs in most developed countries. Conditions for which newborn screening is now a recognized preventative public health initiative include phenylketonuria (PKU), congenital hypothyroidism (CHT), and, more recently, cystic fibrosis (CF) and sickle cell disorder (SCD). The use of tandem mass spectrometry to detect conditions such as amino-acidopathies and fatty-acid oxidation defects is also becoming increasingly prevalent.The author thanks Dr. David Aitken, Dr. Richard Ashcroft, Professor Carol Dezateux, Dr. Katrina Hargreaves, Dr. Sandy Oliver, Dr. Rosalind Skinner, Ruth Stewart, and two anonymous referees for their valuable comments in drafting this paper.

Type
SPECIAL SECTION: THE POWER OF CHOICE: AUTONOMY, INFORMED CONSENT, AND THE RIGHT TO REFUSE
Copyright
© 2006 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)